RecruitingPhase 2NCT07647198

FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

FATIMA Trial: EGCG and Vitamin D3 for Secondary Prevention of Uterine Fibroids

Sponsor

Sheikh Shakhbout Medical City

Enrollment

240 participants

Start Date

Aug 22, 2026

Study Type

INTERVENTIONAL

Conditions

Uterine Fibroids (Leiomyoma)

Summary

The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and Vitamin D and Green Tea for people with uterine fibroids (leiomyoma). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTVitamin D and Green Tea

EGCG and Vitamin D3 (300 mg, 2000 IU respectively, in tablets Each tablet will contain 150 mg EGCG, 1000 IU Vitamin D

OTHERPlacebo

The placebo has no medication and the participant will receive standard of care.

Locations(1)

Sheikh Shakbhout Medical City

Abu Dhabi, United Arab Emirates (uae), United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07647198

Related Trials

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

NCT074807851 location

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

NCT073527612 locations